Diana Michele, Halvax Peter, Mertz Damien, Legner Andras, Brulé Jean-Marcel, Robinet Eric, Mutter Didier, Pessaux Patrick, Marescaux Jacques
Institute for Minimally Invasive Image-Guided Surgery, Strasbourg, France Research Institute Against Cancer of the Digestive System, Strasbourg, France
Institute for Minimally Invasive Image-Guided Surgery, Strasbourg, France.
Surg Innov. 2015 Jun;22(3):217-22. doi: 10.1177/1553350615577483. Epub 2015 Mar 22.
Image fusion between ultrasound (US) and computed tomography (CT) scan or magnetic resonance can increase operator accuracy in targeting liver lesions, particularly when those are undetectable with US alone. We have developed a modular gel to simulate hepatic solid lesions for educational purposes in imaging and minimally invasive ablation techniques. We aimed to assess the impact of image fusion in targeting artificial hepatic lesions during the hands-on part of 2 courses (basic and advanced) in hepatobiliary surgery.
Under US guidance, 10 fake tumors of various sizes were created in the livers of 2 pigs, by percutaneous injection of a biocompatible gel engineered to be hyperdense on CT scanning and barely detectable on US. A CT scan was obtained and a CT-US image fusion was performed using the ACUSON S3000 US system (Siemens Healthcare, Germany). A total of 12 blinded course attendants, were asked in turn to perform a 10-minute liver scan with US alone followed by a 10-minute scan using image fusion.
Using US alone, the expert managed to identify all lesions successfully. The true positive rate for course attendants with US alone was 14/36 and 2/24 in the advanced and basic courses, respectively. The total number of false positives identified was 26. With image fusion, the rate of true positives significantly increased to 31/36 (P < .001) in the advanced group and 16/24 in the basic group (P < .001). The total number of false positives, considering all participants, decreased to 4 (P < .001).
Image fusion significantly increases accuracy in targeting hepatic lesions and might improve echo-guided procedures.
超声(US)与计算机断层扫描(CT)或磁共振成像融合可提高操作者对肝脏病变的靶向准确性,尤其是在仅靠超声无法检测到病变时。我们开发了一种模块化凝胶,用于模拟肝脏实性病变,以用于成像和微创消融技术的教学目的。我们旨在评估在肝胆外科的2门课程(基础和高级)的实践部分中,图像融合对靶向人工肝病变的影响。
在超声引导下,通过经皮注射一种生物相容性凝胶,在2头猪的肝脏中制造了10个大小各异的假肿瘤,该凝胶经设计在CT扫描上为高密度,而在超声上几乎无法检测到。进行了CT扫描,并使用ACUSON S3000超声系统(德国西门子医疗)进行了CT-US图像融合。总共12名不知情的课程参与者依次被要求先用超声进行10分钟的肝脏扫描,然后使用图像融合进行10分钟的扫描。
仅使用超声时,专家成功识别出了所有病变。在高级课程和基础课程中,参与者仅使用超声时的真阳性率分别为14/36和2/24。识别出的假阳性总数为26个。使用图像融合时,高级组的真阳性率显著提高到31/36(P <.001),基础组为16/24(P <.001)。考虑所有参与者,假阳性总数降至4个(P <.001)。
图像融合显著提高了靶向肝病变的准确性,并可能改善超声引导下的操作。